Jaguar Health Inc logo

JAGX

Materials

Jaguar Health Inc

$2.82-0.19 (-6.31%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving JAGX Today?

No stock-specific AI insight has been generated for JAGX yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$1M
P/E Ratio
EPS
Dividend Yield
Dividend / Share
ROE
Profit Margin
Debt / Equity

Trading

Volume239K
Avg Volume (10D)
Shares Outstanding372K

JAGX News

20 articles

All 20 articles loaded

Price Data

Open$3.19
Previous Close$3.01
Day High$3.19
Day Low$2.53
52 Week High
52 Week Low

About Jaguar Health Inc

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

47 employees
Listed May 13, 2015
MaterialsPHARMACEUTICAL PREPARATIONS

Company Details

Security TypeStock
ExchangeNASDAQ
Currency
Round Lot
SICPHARMACEUTICAL PREPARATIONS
CIK
Composite FIGI
Share Class FIGI